Wednesday, July 8, 2026

pharma · Diabetic Macular Edema · Non-infectious Uveitis Affecting the Posterior Segment of the Eye · ANIP

ANI PHARMACEUTICALS

ANI PHARMACEUTICALS clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

500 Alexander Park, Princeton, New Jersey 08540, US HQ
678 Employees
Public company Type
ANIP · NYSE Ticker
Company details
Status
Public
HQ
500 Alexander Park, Princeton, New Jersey 08540, US
Employees
678
Programs
11
Drugs
7
Patents
7
Intelligence · Clinical Programs

ANI PHARMACEUTICALS projects

11 ClinicalTrials.gov programs sponsored by ANI PHARMACEUTICALS.

ANI PHARMACEUTICALS has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Yutiq 0.18 MG Drug Implant

    ANI PHARMACEUTICALS INC

    Uveitis

    phase 3 small molecule active

    1 trial
  2. fluocinolone acetonide

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema

    phase 3 small molecule completed

    3 trials
  3. Fluocinolone Acetonide

    ANI PHARMACEUTICALS INC

    Age-Related Macular Degeneration

    phase 2 small molecule terminated

    1 trial
  4. Fluocinolone Acetonide

    ANI PHARMACEUTICALS INC

    Macular Edema

    phase 2 small molecule terminated

    1 trial
  5. Fluocinolone Acetonide Intravitreal Implant 0.18 mg

    ANI PHARMACEUTICALS INC

    Uveitis, Posterior

    approved small molecule active

    1 trial
  6. ILUVIEN

    ANI PHARMACEUTICALS INC

    Chronic Diabetic Macular Edema

    approved small molecule completed

    1 trial
  7. ILUVIEN 0.19 MG

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema (DME)

    approved small molecule completed

    1 trial
  8. Iluvien 0.19 MG Drug Implant

    ANI PHARMACEUTICALS INC

    Diabetic Macular Edema

    approved small molecule active

    1 trial
  9. Purified Cortophin Gel, 40 U

    ANI PHARMACEUTICALS INC

    Gout Arthritis

    approved small molecule active

    1 trial
  10. fluocinolone acetonide 190 micrograms

    ANI PHARMACEUTICALS INC

    Non-infectious Uveitis Affecting the Posterior Segment of the Eye

    approved small molecule active

    1 trial
  11. Misoprostol 25 µg Vaginal

    ANI PHARMACEUTICALS INC

    Cervical Ripening

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does ANI PHARMACEUTICALS have?

11 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.